Administrative Core
行政核心
基本信息
- 批准号:10246888
- 负责人:
- 金额:$ 17.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressBiometryBrain NeoplasmsBudgetsCollaborationsCommunicationComplexComprehensive Cancer CenterConflict of InterestDataData ProvenanceDepartment chairDoctor of MedicineDoctor of PhilosophyEnsureEvaluationExpenditureFosteringFundingGlioblastomaGoalsGrantGuidelinesHuman ResourcesImmunotherapeutic agentImmunotherapyInformaticsInfrastructureInstitutesInstitutionInternationalInvestigational TherapiesLeadershipMalignant NeoplasmsMaster of Business AdministrationMonitorOccupational activity of managing financesOffice of Administrative ManagementPatient-Focused OutcomesPatientsPoliciesPreparationProcessProductivityProgram EvaluationProgram Research Project GrantsPublicationsRegulationReportingResearchResearch PersonnelResearch Project GrantsResource SharingScheduleScienceStructureTimeTrainingUnited States National Institutes of HealthUniversitiesVisionVisitclinical developmentcohesionconflict resolutiondata integritydata managementexperienceimproved outcomemeetingsneuro-oncologyneurosurgerynoveloncology programoperationprofessorprogramsquality assurancestem
项目摘要
PROJECT SUMMARY – Administrative Core
The Administrative Core is responsible for organizing and supporting three research projects and three
scientific cores in this Program. The Core provides leadership, infrastructure, and support personnel to
facilitate administrative management; promote integration, communication, and collaboration; ensure fiscal and
regulatory compliance; and oversee data operations, scientific rigor and research progress. The Administrative
Core will oversee the Program's organizational infrastructure and day-to-day administrative activities; serve as
the liaison with all internal and external constituencies; provide clerical support for document preparation;
foster team science by facilitating collaboration and communication through regular meetings, seminars, and
other interactions; provide fiscal management to ensure timely financial accounting and reporting according to
university and NIH policies; provide regulatory support to ensure compliance with institutional, state, and
federal research guidelines; oversee data operations to ensure use of best practices for data provenance and
integrity (e.g. monitoring standards such as SOPs, GCP, GMP); provide scientific management by monitoring
research progress/productivity and effective use of shared resource cores relative to scientific milestones and
budgeted expenditures; conduct rigorous Program evaluations, with guidance and direction provided by
Internal and External Advisory Boards; manage resource sharing and conflict resolution; and delineate specific
publication and data distribution policies. By serving these functions, the Administrative Core reduces
administrative burden, allowing the Program investigators to focus on developing novel immunotherapies for
patients with glioblastoma (GBM).
项目摘要 - 行政核心
行政核心负责组织和支持三个研究项目和三个
该计划中的科学核心。核心提供领导,基础设施和支持人员
促进行政管理;促进集成,沟通和协作;确保财政和
法规合规;并监督数据操作,科学严谨和研究进度。行政
核心将监督该计划的组织基础架构和日常行政活动;充当
与所有内部和外部选区的联络;为文档准备提供文书支持;
通过常规会议,半手赛和
其他互动;提供财政管理以确保及时的财务会计和报告
大学和NIH政策;提供监管支持以确保遵守机构,国家和
联邦研究指南;监督数据操作,以确保使用最佳实践进行数据出处和
完整性(例如,监视标准,例如SOP,GCP,GMP);通过监视提供科学管理
研究进度/生产力以及相对于科学里程碑的共享资源核心的有效利用
预算支出;进行严格的计划评估,并提供指导和指导
内部和外部咨询委员会;管理资源共享和冲突解决方案;并描述了具体的
出版和数据分发政策。通过服务这些功能,管理核心减少
行政烧伤,允许计划调查人员专注于开发新型免疫疗法
胶质母细胞瘤(GBM)患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN H. SAMPSON其他文献
JOHN H. SAMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN H. SAMPSON', 18)}}的其他基金
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
项目 1:通过消除调节性 T 细胞来靶向胶质母细胞瘤中的巨细胞病毒抗原
- 批准号:
10006177 - 财政年份:2018
- 资助金额:
$ 17.53万 - 项目类别:
Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy
通过疫苗预处理进行巨细胞病毒靶向治疗的临床脑肿瘤开发,以验证疫苗功效的新预测因子
- 批准号:
10310436 - 财政年份:2018
- 资助金额:
$ 17.53万 - 项目类别:
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
项目 1:通过消除调节性 T 细胞来靶向胶质母细胞瘤中的巨细胞病毒抗原
- 批准号:
10246884 - 财政年份:2018
- 资助金额:
$ 17.53万 - 项目类别:
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
CCL3 作为一种增强脑肿瘤治疗的发育疗法
- 批准号:
10055778 - 财政年份:2016
- 资助金额:
$ 17.53万 - 项目类别:
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
CCL3 作为一种增强脑肿瘤治疗的发育疗法
- 批准号:
9216208 - 财政年份:2016
- 资助金额:
$ 17.53万 - 项目类别:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
人 EGFRvIII 特异性 BiTE 用于治疗胶质母细胞瘤
- 批准号:
9750830 - 财政年份:2015
- 资助金额:
$ 17.53万 - 项目类别:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
人 EGFRvIII 特异性 BiTE 用于治疗胶质母细胞瘤
- 批准号:
9095464 - 财政年份:2015
- 资助金额:
$ 17.53万 - 项目类别:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
人 EGFRvIII 特异性 BiTE 用于治疗胶质母细胞瘤
- 批准号:
8803629 - 财政年份:2015
- 资助金额:
$ 17.53万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
- 批准号:
10638247 - 财政年份:2023
- 资助金额:
$ 17.53万 - 项目类别:
Mapping the Neurobiological Risks and Consequences of Alcohol Use in Adolescence and Across the Lifespan
绘制青春期和整个生命周期饮酒的神经生物学风险和后果
- 批准号:
10733406 - 财政年份:2023
- 资助金额:
$ 17.53万 - 项目类别:
Substance use treatment and county incarceration: Reducing inequities in substance use treatment need, availability, use, and outcomes
药物滥用治疗和县监禁:减少药物滥用治疗需求、可用性、使用和结果方面的不平等
- 批准号:
10585508 - 财政年份:2023
- 资助金额:
$ 17.53万 - 项目类别: